PharmaCyte Biotech, Inc. (PMCB)

NASDAQ: PMCB · Real-Time Price · USD

0.4913

+0.0106 (2.21%)

At close: Sep 3, 2026, 4:00 PM EDT

0.5000

+0.0087 (1.77%)

Pre-market: Sep 4, 2026, 8:37 AM EDT

PharmaCyte Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 3, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Market Capitalization	5	8	9	18	51	48
Market Cap Growth	-16.28%	-8.93%	-52.51%	-64.81%	5.50%	14.27%
Enterprise Value	-32	-12	-8	-20	-22	-38
Last Close Price	0.49	0.72	1.24	2.12	2.92	2.33

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 3, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
PE Ratio	-	-	0.36	-	-	-
PB Ratio	0.16	0.22	0.16	0.45	0.70	0.54
P/TBV Ratio	0.16	0.23	0.17	0.69	0.74	0.56

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 3, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Net Debt / Equity Ratio	-1.06	-1.06	-0.30	-1.27	-0.94	-0.95
Quick Ratio	45.16	45.16	5.33	6.76	115.99	121.24
Current Ratio	45.28	45.28	7.68	6.80	116.18	121.38
Return on Equity (ROE)	-44.72%	-44.72%	67.08%	0.60%	-5.31%	-8.78%
Return on Assets (ROA)	-6.50%	-6.50%	-4.75%	-6.12%	-4.92%	-5.60%
Return on Capital Employed (ROCE)	-11.50%	-11.50%	-8.40%	-12.40%	-8.90%	-4.90%

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 3, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Earnings Yield	-439.98%	-250.60%	360.19%	1.86%	-8.47%	-8.78%
Buyback Yield / Dilution	-14.31%	-14.31%	23.50%	50.84%	-25.56%	-971.73%

SEC Filings: 10-K · 10-Q